Lgt Fund Management CO Ltd. Halozyme Therapeutics, Inc. Transaction History
Lgt Fund Management CO Ltd.
- $1.09 Billion
- Q2 2025
A detailed history of Lgt Fund Management CO Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 33,600 shares of HALO stock, worth $2.16 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
33,600Holding current value
$2.16 Million% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
584Shares Held
121MCall Options Held
315KPut Options Held
183K-
Black Rock Inc. New York, NY17.6MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$787 Million0.01% of portfolio
-
State Street Corp Boston, MA6.05MShares$389 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$223 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$218 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.95B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...